Annual tuberculosis screening in patients on biologics has questionable value

J Am Acad Dermatol. 2024 Mar 11:S0190-9622(24)00484-5. doi: 10.1016/j.jaad.2024.02.051. Online ahead of print.

¹ The Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
² Department of Dermatology, UMass Medical Center, Worcester, Massachusetts.
³ Department of Dermatology, Milton S. Hershey Penn State Medical Center, Hershey, Pennsylvania.
⁴ Department of Public Health Sciences, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
⁵ Department of Dermatology, Milton S. Hershey Penn State Medical Center, Hershey, Pennsylvania; Department of Public Health Sciences, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
⁶ Department of Dermatology, Milton S. Hershey Penn State Medical Center, Hershey, Pennsylvania. Electronic address: mhelm2@pennstatehealth.psu.edu.

No abstract available

Keywords: biologic agent; interferon-gamma release assays; latent tuberculosis infection; purified protein derivative skin test.